SCHEMBL20038075

SCHEMBL20038075

Cc1ccc(N2CCNC(C)(C)C2=O)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.46
DRD3 P35462 1/20 0.41
KCNH2 Q12809 1/20 0.41
GRM4 Q14833 1/20 0.39
CHRNB2 P17787 1/20 0.36
CHRNA4 P43681 1/20 0.36
P2RX7 Q99572 4/20 0.35
EGLN1 Q9GZT9 2/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
PIK3CD O00329 1/20 0.33
DGAT1 O75907 2/20 0.33
AR P10275 1/20 0.33
CCNT1 O60563 1/20 0.32
CDK4 P11802 1/20 0.32
CCND1 P24385 1/20 0.32
CCND3 P30281 1/20 0.32
CDK7 P50613 1/20 0.32
CDK9 P50750 1/20 0.32
CCNH P51946 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18291456 0.85 CHRNB2 (0.36) GRM4CHRNB2CHRNA4RAB9ASMN1; SMN2
SCHEMBL20038045 0.84 RAB9A (0.33) ELANECHRNB2CHRNA4RAB9ASMN1; SMN2
SCHEMBL20038025 0.82 ELANE (0.46) ELANEDRD3KCNH2GRM4CHRNB2
SCHEMBL20249234 0.82 OPRL1 (0.34) ELANERAB9ASMN1; SMN2PIK3CDAR
SCHEMBL18096248 0.79 AR (0.55) ELANEDRD3CHRNB2CHRNA4AR
SCHEMBL14490582 0.78 DRD3 (0.44) ELANEDRD3KCNH2CHRNB2CHRNA4
SCHEMBL18291196 0.77 CDK4 (0.42) ELANEDRD3KCNH2GRM4CHRNB2
SCHEMBL18291199 0.76 EGLN1 (0.46) ELANEDRD3KCNH2EGLN1CDK4
SCHEMBL19913872 0.75 AR (0.39) GRM4P2RX7EGLN1RAB9ASMN1; SMN2
SCHEMBL19913877 0.75 AR (0.50) GRM4EGLN1RAB9ASMN1; SMN2PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305785-A1 PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2018-04-11 EP disclosed